Institute for Hygiene and Environmental Medicine, Ernst Moritz Arndt University, Greifswald, Germany.
Skin Pharmacol Physiol. 2011;24(6):337-41. doi: 10.1159/000330761. Epub 2011 Aug 11.
The efficacy of antimicrobial compounds included in wound dressings has been determined using the quantitative suspension test according to EN 13727 before. However, as suspension tests are not an accurate reflection of the conditions under which wound antiseptics are used, it was investigated if a disc carrier test would yield results simulating practical conditions on wound surfaces. A silver-leaching foam wound dressing was used for evaluation of the disc carrier test method.
The disc carriers consisted of circular stainless-steel discs measuring 2 cm in diameter and 1.5 mm in thickness, complying with the requirements of EN 10088-2. Carriers were contaminated with Staphylococcus aureus, methicillin-resistant S. aureus or Pseudomonas aeruginosa, respectively, together with an artificial wound secretion and left to dry at room temperature for 30 min. The wound dressings being tested were placed on the discs for the length of the exposure time, and after neutralization by thioglycolate in phosphate-buffered saline the number of surviving test organisms was then counted. The logarithmic reduction factor was calculated from the difference between the initial inoculum and the number of recovered test organisms.
The disc carrier test allowed determination of an antimicrobial efficacy in a realistic setting. It also imposed more stringent requirements on efficacy over time than the quantitative suspension test. The silver foam wound dressing showed a time-dependent antimicrobial efficacy. After 24-hour application time, the reduction factors against S. aureus, P. aeruginosa and the methicillin-resistant S. aureus were 1.9 ± 0.15, 2.1 ± 0.14 and 3.1 ± 0.18, respectively.
The disc carrier test was a useful method for testing the antimicrobial efficacy of a foam silver dressing. The antimicrobial dressing exhibited an antimicrobial effect after 3 h and achieved a reduction >2 log against the tested bacterial strains in the presence of a simulated wound secretion after 24 h.
根据 EN 13727 标准,以前已经使用定量悬浮试验来确定包含在伤口敷料中的抗菌化合物的功效。然而,由于悬浮试验不能准确反映伤口防腐剂使用的条件,因此研究了圆盘载体试验是否会产生模拟伤口表面实际条件的结果。使用一种含银的渗液泡沫伤口敷料来评估圆盘载体试验方法。
圆盘载体由直径为 2 厘米、厚度为 1.5 毫米的圆形不锈钢盘组成,符合 EN 10088-2 的要求。载体分别与金黄色葡萄球菌、耐甲氧西林金黄色葡萄球菌或铜绿假单胞菌一起污染,并在室温下干燥 30 分钟。正在测试的伤口敷料被放置在圆盘上,暴露时间长度,然后用磷酸盐缓冲盐水中的巯基醋酸中和,然后计算存活的测试生物数量。对数减少因子是从初始接种物和回收的测试生物数量之间的差异计算得出的。
圆盘载体试验允许在现实环境中确定抗菌功效。它还对功效随着时间的推移提出了比定量悬浮试验更严格的要求。含银泡沫伤口敷料显示出时间依赖性的抗菌功效。在 24 小时的应用时间后,对金黄色葡萄球菌、铜绿假单胞菌和耐甲氧西林金黄色葡萄球菌的减少因子分别为 1.9±0.15、2.1±0.14 和 3.1±0.18。
圆盘载体试验是一种测试泡沫银敷料抗菌功效的有用方法。这种抗菌敷料在 3 小时后表现出抗菌效果,在模拟伤口分泌物存在的情况下,在 24 小时后对测试的细菌菌株达到 >2 对数减少。